Trademark: 79311198
Status Date
Tuesday, January 11, 2022
Registration Number
6610357
Registration Date
Tuesday, January 11, 2022
Filing Date
Friday, February 26, 2021
Published for Opposition
Tuesday, October 26, 2021
5 Pharmaceutical preparations and substances for use in gene therapy, namely, for treatment of sickle cell disease
Dec 23, 2023
Change Of Name/Address Rec'd From Ib
Aug 26, 2022
Change Of Name/Address Rec'd From Ib
May 23, 2022
Notification Processed By Ib
May 3, 2022
Final Disposition Notice Sent To Ib
May 2, 2022
Final Disposition Processed
Feb 10, 2022
Grant Of Protection Created, To Be Sent To Ib
Jan 20, 2022
Change Of Owner Received From Ib
Jan 11, 2022
Registered-Principal Register
Jan 3, 2022
Limitation From The Ib Examined, No Action Is Needed
Nov 13, 2021
Limitation Of Goods Received From Ib
Oct 26, 2021
Published For Opposition
Oct 6, 2021
Notice Of Publication
Sep 21, 2021
Approved For Pub - Principal Register
Sep 21, 2021
Assigned To Examiner
Aug 23, 2021
Limitation From The Ib Examined And Entered
Aug 21, 2021
Limitation Of Goods Received From Ib
May 25, 2021
Application Filing Receipt Mailed
May 21, 2021
New Application Office Supplied Data Entered
May 20, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
